31 Oct R5 Pharmaceuticals
Posted at 14:18h in
R5 Pharmaceuticals developed and manufactured dosage forms for clinical trials. Their unique approach was essential to provide the right product on time and on budget. As a consequence of their track record at achieving this, R5 was acquired in 2010 by Aesica Pharma generating BioCity a healthy return (44X).
